We are live on
!
Find out more
Federated Hermes Portfolio holdings
AUM
$69.6B
1-Year Est. Return
42.52%
This Fund
S&P 500
This Quarter
Est. Return
-2.1%
1 Year Est. Return
+42.52%
3 Year Est. Return
+132.48%
5 Year Est. Return
+152.58%
10 Year Est. Return
+652.43%
AUM
$34.1B
AUM Growth
-$2.63B
(-7.2%)
Cap. Flow
-$362M
Cap. Flow
% of AUM
-1.06%
Top 10 Holdings %
Top 10 Hldgs %
13.14%
Holding
2,315
New
186
Increased
813
Reduced
981
Closed
182
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan Chase
JPM
|
+$283M |
| 2 |
Medtronic
MDT
|
+$96M |
| 3 |
Philip Morris
PM
|
+$80.4M |
| 4 |
United Parcel Service
UPS
|
+$75.5M |
| 5 |
Dominion Energy
D
|
+$74.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Cardinal Health
CAH
|
+$178M |
| 2 |
General Mills
GIS
|
+$158M |
| 3 |
ExxonMobil
XOM
|
+$138M |
| 4 |
ServiceNow
NOW
|
+$96M |
| 5 |
Keysight
KEYS
|
+$72.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 23.14% |
| 2 | Financials | 15.14% |
| 3 | Technology | 13.55% |
| 4 | Consumer Discretionary | 8.1% |
| 5 | Consumer Staples | 7.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
626
Goldman Sachs
GS
$273B
| $6.41M | 0.02% |
21,887
+184
| +0.8% | +$59.6K |
|
627
LendingTree
TREE
$373M
| $6.37M | 0.02% |
267,026
+6,236
| +2% | +$243K |
|
628
Fidelity National Financial
FNF
$11.5B
| $6.34M | 0.02% |
182,084
-60,097
| -25% | -$2.24M |
|
629
Arch Capital
ACGL
$33.1B
| $6.29M | 0.02% |
138,117
-18,721
| -12% | -$846K |
|
630
Cboe Global Markets
CBOE
$28.2B
| $6.29M | 0.02% |
53,585
+18,867
| +54% | +$2.27M |
|
631
Watts Water Technologies
WTS
$11.6B
| $6.25M | 0.02% |
49,714
+10,927
| +28% | +$1.48M |
|
|
CELL
632
DELISTED
PhenomeX Inc. Common Stock
CELL
| $6.22M | 0.02% |
2,175,776
-331,365
| -13% | -$1.41M |
|
633
Algonquin Power & Utilities
AQN
$4.1B
| $6.16M | 0.02% |
565,021
-1,121
| -0.2% | -$15.2K |
|
|
SUM
634
DELISTED
Summit Materials, Inc. Class A Common Stock
SUM
| $6.11M | 0.02% |
259,525
-1,857
| -0.7% | -$49.9K |
|
635
Hain Celestial
HAIN
$53.2M
| $6.05M | 0.02% |
358,213
+331,666
| +1,249% | +$7.13M |
|
636
Globant
GLOB
$1.66B
| $6.01M | 0.02% |
32,153
+286
| +0.9% | +$59K |
|
637
KB Home
KBH
$2.98B
| $6.01M | 0.02% |
231,971
+222,993
| +2,484% | +$6.7M |
|
638
Baxter International
BAX
$12.2B
| $5.97M | 0.02% |
110,846
-4,115
| -4% | -$248K |
|
639
Western Union
WU
$2.04B
| $5.91M | 0.02% |
437,410
-4,575,475
| -91% | -$71.7M |
|
640
Phillips 66
PSX
$106B
| $5.9M | 0.02% |
73,116
+36,142
| +98% | +$3.08M |
|
641
Tenaris
TS
$28.4B
| $5.86M | 0.02% |
226,706
+28,730
| +15% | +$760K |
|
|
MRC
642
DELISTED
MRC Global
MRC
| $5.86M | 0.02% |
814,271
-2,128
| -0.3% | -$21K |
|
|
PCH
643
DELISTED
PotlatchDeltic
PCH
| $5.85M | 0.02% |
142,600
-5,147
| -3% | -$236K |
|
|
VMEO
644
DELISTED
Vimeo
VMEO
| $5.84M | 0.02% |
1,459,291
+1,459,014
| +526,720% | +$8.63M |
|
645
Kennametal
KMT
$2.27B
| $5.8M | 0.02% |
281,789
+112,079
| +66% | +$2.72M |
|
646
Teladoc Health
TDOC
$1.17B
| $5.74M | 0.02% |
226,307
+102,886
| +83% | +$3.61M |
|
647
Parsons
PSN
$4.97B
| $5.71M | 0.02% |
145,653
+99,751
| +217% | +$4.14M |
|
648
Mitek Systems
MITK
$799M
| $5.7M | 0.02% |
622,298
+126,204
| +25% | +$1.27M |
|
649
Prestige Consumer Healthcare
PBH
$2.22B
| $5.68M | 0.02% |
113,969
+8,862
| +8% | +$491K |
|
650
Dentsply Sirona
XRAY
$2.02B
| $5.64M | 0.02% |
198,999
+79,027
| +66% | +$2.7M |
|
Similar funds
Federated Hermes's Q3 2022 Portfolio in Review
As of Q3 2022, Federated Hermes held 2,315 positions worth $34.1B, down 7.2% from $36.8B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Federated Hermes's Q3 2022 filing shows 186 new, 813 increased, 981 reduced and 182 closed positions. Its largest new stake was Amylyx Pharmaceuticals: 1,329,000 shares worth $37.4M. The largest sale was Cardinal Health, an estimated $178M.
By sector, the portfolio is most concentrated in Healthcare at 23% of assets, up from 23% a quarter earlier, followed by Financials and Technology.
- Federated Hermes's largest Q3 2022 buy was Amylyx Pharmaceuticals: 1,329,000 shares worth $37.4M.
- Federated Hermes added most to JPMorgan Chase in Q3 2022, an estimated $283M increase.
- Federated Hermes's biggest Q3 2022 reduction was Cardinal Health, cutting an estimated $178M.
- Federated Hermes fully exited Turning Point Therapeutics, Inc. Common Stock in Q3 2022, selling an estimated $69.1M.
- Federated Hermes's ten largest holdings make up 13% of its $34.1B portfolio in Q3 2022.
- Federated Hermes opened 186 new positions and closed 182 in Q3 2022.
- Federated Hermes's portfolio value fell 7.2% quarter-over-quarter to $34.1B.
Based on Federated Hermes's 13F filing for Q3 2022, filed 14 Nov 2022.